Metachromatic Leukodystrophy Mld clinical trials

Explore recruiting metachromatic leukodystrophy mld clinical trials.

Recruiting metachromatic leukodystrophy mld studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metachromatic Leukodystrophy Mld trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single arm, open label, clinical study of cryopreserved autologous CD34+ cells transduced with lentiviral vector containing human ARSA cDNA, for the treatment of early onset Metachromatic Leukodystrophy (MLD)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I/II clinical trial of hematopoietic stem cell gene therapy for the treatment of Metachromatic Leukodystrophy

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Global, Multicenter, Single-arm, Matched External Control Study of Intrathecal SHP611 in Subjects with Late Infantile Metachromatic Leukodystrophy

Germany, France, Belgium, Greece, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label Extension of Study HGT-MLD-070 Evaluating Long Term Safety and Efficacy of Intrathecal Administration of HGT-1110 in Patients with Metachromatic Leukodystrophy

Czechia, Denmark, Germany, France, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Proof-of-Concept Study to Explore the Potential Efficacy of Deferiprone in Patients With Pelizaeus-Merzbacher disease (PMD)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label, non-randomized trial to evaluate the safety and efficacy of a single infusion of OTL-200 in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metachromatic Leukodystrophy Mld trials by city

Metachromatic Leukodystrophy Mld in Toronto Metachromatic Leukodystrophy Mld in Vancouver Metachromatic Leukodystrophy Mld in Montreal Metachromatic Leukodystrophy Mld in Calgary Metachromatic Leukodystrophy Mld in Edmonton Metachromatic Leukodystrophy Mld in Ottawa Metachromatic Leukodystrophy Mld in Winnipeg Metachromatic Leukodystrophy Mld in Quebec City Metachromatic Leukodystrophy Mld in Hamilton Metachromatic Leukodystrophy Mld in Kitchener Metachromatic Leukodystrophy Mld in London Metachromatic Leukodystrophy Mld in Halifax Metachromatic Leukodystrophy Mld in New York Metachromatic Leukodystrophy Mld in Los Angeles Metachromatic Leukodystrophy Mld in Chicago Metachromatic Leukodystrophy Mld in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease